Top 200 Drugs Podcast – Medications 186-190

Antiarrhythmic medications are some of the most complex and high-risk drugs pharmacists encounter in clinical practice. In this episode, we break down the most important concepts pharmacists need to understand about antiarrhythmics, including the major drug classes and the clinic ...  Show more

P2Y12 inhibitors are a cornerstone of antiplatelet therapy in cardiovascular disease. These agents block the P2Y12 receptor on platelets, preventing ADP-mediated activation and reducing platelet aggregation. By inhibiting this amplification pathway, they help prevent arterial thr ...  Show more

Many patients with type 2 diabetes take oral antidiabetic medications, either as monotherapy or in conjunction with other oral antidiabetic medications or insulin. It’s important you are able to recognize these medications as their use increases the risk of hypoglycemia, especial ...  Show more

The immune system doesn’t make mistakes, we just stopped asking why it showed up. If you’ve been diagnosed with multiple autoimmune diseases, here’s what conventional medicine won’t investigate: your immune system isn’t attacking you for no reason, it’s protecting you from pathog ...  Show more

The same brain circuits involved in drug and alcohol addiction are hijacked by ultra-processed foods, and dynorphins are the key players. These peptides attach to kappa opioid receptors, initially reducing dopamine and creating dysphoria that drives you to seek more food rewards. ...  Show more

More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed by John Mandrola, MD. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit ...  Show more